Real-time enrollment status for this gata2 clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 1:46 AM UTC
| NCT Number | NCT01861106 |
| Recruiting Status | Recruiting |
| Condition | GATA2 |
| Phase | PHASE2 |
| Target Enrollment | 144 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 16, 2026 (3 days ago) |
As of October 19, 2026: Clinical trial NCT01861106 is currently recruiting participants. This phase2 study for gata2 is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01861106 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01861106 was last updated 3 days ago (October 16, 2026). HelloStudys verifies this status automatically.